Opportunity
Simpler Grants.gov #CDC-RFA-CK-26-0107
CDC Cooperative Agreement for National Infectious Disease Prevention and Response Partnerships
Buyer
National Center for Emerging and Zoonotic Infectious Diseases
Posted
October 04, 2023
Respond By
April 18, 2026
Identifier
CDC-RFA-CK-26-0107
NAICS
923120, 813212, 813319
The Centers for Disease Control and Prevention (CDC), through its National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), is seeking partners to enhance the nation's ability to prevent and respond to infectious disease threats. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) - OEMs and Vendors: - No specific OEMs or vendors are named in this opportunity - Products/Services Requested: - National partnership services to build and sustain critical infrastructure for infectious disease prevention and response - Workforce training for clinicians, healthcare professionals, and public health staff - Communication strategies to support infection prevention and control - Emergency response capabilities, including surge staffing and antimicrobial resistance initiatives - Unique or Notable Requirements: - Open to a wide range of eligible applicants, including government entities, tribal organizations, educational institutions, nonprofits, and businesses - No cost sharing or matching required - Cooperative agreement funding instrument - Awards range from $1,000,000 to $30,000,000, with total estimated funding of $150,000,000 - Focus on national impact and capacity building for infectious disease prevention and response
Description
This cooperative agreement aims to enhance the nation's ability to prevent, detect, and respond to infectious disease threats by supporting clinicians, healthcare professionals, healthcare systems, institutions, and organizations involved in patient care and public health. The program focuses on building critical infrastructure, workforce training, communication strategies, and emergency response capabilities to address emerging and reemerging infectious diseases. It emphasizes expanding national infection prevention capacity through education and training, particularly in antimicrobial resistance and infection control, and supports surge staffing and coordination during emergency responses.